HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

LSN862

peroxisome proliferator-activated receptor (PPAR)alpha/gamma dual agonist with a unique in vitro profile that shows improvements on glucose and lipid levels in rodent models of type 2 diabetes and dyslipidemia; structure in first source
Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Johnson, Jeffrey A: 1 article (01/2013)
2. Johnson, Delinda A: 1 article (01/2013)
3. Emborg, Marina E: 1 article (01/2013)
4. Swanson, Christine R: 1 article (01/2013)
5. Du, Eric: 1 article (01/2013)
6. Rojo, Isabel: 1 article (06/2005)
7. Zink, Richard: 1 article (06/2005)
8. Rafaeloff-Phail, Ronit: 1 article (06/2005)
9. Brozinick, Joseph T: 1 article (06/2005)
10. Klausing, Kay: 1 article (06/2005)

Related Diseases

1. Parkinson Disease (Parkinson's Disease)
2. Dyslipidemias (Dyslipidemia)

Related Drugs and Biologics

1. Peroxisome Proliferator-Activated Receptors (PPAR)
2. leustroducsin A
3. PPAR alpha
4. Glucose (Dextrose)